Abstract
1. Abstract
Insulin Resistance is the leading cause of Type 2 diabetes mellitus (T2D). It occurs as a result of lipid disorders and increased levels of circulating free fatty acids (FFAs). FFAs accumulate within the insulin sensitive tissues such as muscle, liver and adipose tissues exacerbating different molecular mechanisms. Increased levels fatty acid has been documented to be strongly associated with insulin resistant states and obesity causing inflammation that eventually causes type 2-diabetes. Among the biomarkers that are accompanying low grade inflammation include IL-1β, IL-6 and TNF-α. The current review point out the importance of measuring the inflammatory biomarkers especially focusing on the conductance and measurement for IL-6 as a screening laboratory test and its diagnostic value in clinical practice.
Reference92 articles.
1. 1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed; 2017.
2. 2. Menke A, Casagrande S, Geiss L, Cowie CC. Prevalence of and trends in diabetes among adults in the united states. JAMA. 2015; 314: 1021-1029.
3. 3. Dawson KG, Gomes D, Gerstein H, Blanchard JF, Kahler KH. The economic cost of diabetes in Canada. Diabetes Care. 2002; 25: 1303-1307.
4. 4. Canadian Community Health Survey (CCHS) Statistics Canada. Last accessed March 1, 2017.
5. 5. Statistics Canada. Table 13-10-0453-01. Health indicators, age-standardized rate, annual estimates.